Gregory Friedman, M.D., Pediatric Hematology/Oncology, received a Food and Drug Administration (FDA) R01 award for his project, "Ph1 of HSV G207 and Radiation to Treat Pediatric Brain Tumors IND16294," in the amount of $250,000 per year through 2018. Dr. Friedman Awarded FDA Grant for Orphan Product Development Program
Gregory Friedman, M.D., Pediatric Hematology/Oncology, received a Food and Drug Administration (FDA) R01 award for his project, "Ph1 of HSV G207 and Radiation to Treat Pediatric Brain Tumors IND16294," in the amount of $250,000 per year through 2018.